Drug Discovery Product Showcase

  1. Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery 12/18/2025

    From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.

  2. Fast And Reliable Real-Time Imaging 12/5/2025

    This advanced imaging approach uses spatial and morphological data for more detailed analysis, enabling breakthroughs in understanding cell growth, function, and interaction without usual limitations.

  3. Advanced Performance And Fluorochrome Flexibility 12/5/2025

    Achieve top spectral resolution with advanced optical design, quality control, and workflows. Simplify experiments while meeting your panel and fluorochrome needs for high-dimensional flow cytometry.

  4. Immunoassays For Cytokine And Chemokine Quantitation 12/5/2025

    Achieve precise cytokine and chemokine quantitation with flexible immunoassay solutions, including multiplexed bead-based assays, ELISA kits, and ELISPOT reagents, for human, rat, and mouse studies.

  5. Minimize Spillover Spread And Improve Panel Resolution 12/5/2025

    Unlock cleaner flow cytometry data with engineered fluorochromes that reduce spillover and boost resolution. Design complex panels easily across conventional and spectral systems.

  6. Expand Your T-Cell Research With Confidence 12/5/2025

    Achieve deeper T-cell characterization with a panel designed for flexibility. Streamline multicolor panel design, see higher resolution markers, and enable intracellular cytokine detection together.

  7. Altasciences' State-Of-The-Art Research Facilities 12/2/2025

    With over 585,000-sq.-ft. of purpose-built space, our preclinical facilities across North America are designed to support your drug development journey, from early discovery to IND/NDA submission.

  8. Protein Degraders: From Discovery To Development 11/18/2025

    Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.

  9. Powering Production Of Viral Vector-Based Therapies 11/14/2025

    Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.

  10. Comprehensive Suite Of In Vivo And In Vitro Services 11/13/2025

    Accelerate vaccine development with integrated services, supporting all common vaccine types from discovery through IND. Leverage expertise in immunogenicity, dose-response, and efficacy studies.